CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives

Details for Australian Patent Application No. 2007253950 (hide)

Owner Abbott Laboratories

Inventors Gopalakrishnan, Murali; Li, Tao; Lynch, Christopher L.; Ji, Jianguo

Agent Spruson & Ferguson

Pub. Number AU-B-2007253950

PCT Pub. Number WO2007/137030

Priority 60/802,195 19.05.06 US

Filing date 15 May 2007

Wipo publication date 29 November 2007

Acceptance publication date 3 May 2012

International Classifications

C07D 451/08 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

A61K 31/4375 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 451/14 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

22 January 2009 PCT application entered the National Phase

  PCT publication WO2007/137030 Priority application(s): WO2007/137030

3 May 2012 Application Accepted

  Published as AU-B-2007253950

30 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007253952-Implanted system with DC free inputs and outputs

2007253949-Therapeutic fluoroethyl ureas